|
ANAPC10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69700999999023E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.503540E-03 |
| Normal-vs-Stage2 |
2.867800E-02 |
| Normal-vs-Stage3 |
1.81470000137907E-08 |
| Normal-vs-Stage4 |
5.11770000044542E-07 |
| Stage1-vs-Stage2 |
7.555600E-01 |
| Stage1-vs-Stage3 |
1.101180E-03 |
| Stage1-vs-Stage4 |
1.574180E-02 |
| Stage2-vs-Stage3 |
1.672990E-01 |
| Stage2-vs-Stage4 |
2.720600E-01 |
| Stage3-vs-Stage4 |
6.609600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.24159999999696E-05 |
| Normal-vs-AfricanAmerican |
1.137250E-03 |
| Normal-vs-Asian |
1.116030E-01 |
| Caucasian-vs-AfricanAmerican |
9.088200E-01 |
| Caucasian-vs-Asian |
9.651200E-01 |
| AfricanAmerican-vs-Asian |
9.989000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.59600000004811E-06 |
| Normal-vs-Female |
1.321840E-03 |
| Male-vs-Female |
4.450200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.563700E-04 |
| Normal-vs-Age(41-60Yrs) |
1.187500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.44369999999228E-06 |
| Normal-vs-Age(81-100Yrs) |
2.457600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.570400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.230600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.745200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.975200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.209200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.551400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.532200E-01 |
| Normal-vs-Grade 2 |
7.057700E-03 |
| Normal-vs-Grade 3 |
8.17509948625172E-10 |
| Normal-vs-Grade 4 |
6.75129999683222E-08 |
| Grade 1-vs-Grade 2 |
1.910560E-01 |
| Grade 1-vs-Grade 3 |
7.182700E-04 |
| Grade 1-vs-Grade 4 |
1.244010E-03 |
| Grade 2-vs-Grade 3 |
1.584940E-04 |
| Grade 2-vs-Grade 4 |
7.843100E-04 |
| Grade 3-vs-Grade 4 |
2.444400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.226400E-02 |
| Normal-vs-ccB subtype |
2.11389999948963E-08 |
| ccA subtype-vs-ccB subtype |
2.12779999997359E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.624200E-04 |
| Normal-vs-N1 |
3.041300E-03 |
| N0-vs-N1 |
2.934600E-01 |
|
|
